Dr. Christopher Wigfield

About Dr. Christopher Wigfield

Dr. Christopher Wigfield has experience with mesothelioma, conditions in the space between the lungs, chest wall tumors and chest wall defects. He joined Northern Light Cardiothoracic Surgery in Bangor, Maine, in 2023. Favoring minimally invasive approaches, Dr. Wigfield often uses video-assisted and robotic-assisted techniques that can mean smaller incisions, less pain and a faster recovery.

He also collaborates with oncology, radiology and pulmonology teams to build a full personalized treatment plan for each patient. Dr. Wigfield also mentors residents and post-doctoral students in clinical and research settings.

Medical Education & Experience 

• Northern Light Cardiothoracic Surgery
• Royal College of Surgeons of England (Residency)
• University of Wisconsin Hospital and Clinics (Fellowship)
• University of Newcastle-Upon-Tyne (Medical Education)
• Freeman Hospital (Fellowship)
• University of Newcastle (Fellowship)
• Royal Berkshire Hospitals NHS Trust (Internship)
• Newcastle Hospitals NHS Trust (Internship)
• Royal College of Surgeons of England (Fellowship)
• Freie Universität Berlin (M.D.)

Associations, Awards & Recognition

• Cardiothoracic Surgery Network, Member
• Fulbright Scholarship, University of Wisconsin Cardiothoracic Surgery Fellowship
• International Society for Heart and Lung Transplantation, Director for Educational Affairs
• Royal College of Surgeons of England, Fellow
• Society for Cardiothoracic Surgery in Great Britain and Ireland, Member
• Society of Thoracic Surgeons, Member

Why Choose Dr. Wigfield for Pleural Mesothelioma

Dr. Wigfield has decades of experience treating pleural mesothelioma and other complex chest conditions, performing both aggressive surgical procedures and minimally invasive techniques. He holds board certification in cardiothoracic surgery and general surgery. 

His training spans multiple countries and leading academic medical centers. Dr. Wigfield’s care philosophy centers on the individual, aiming for the best possible outcome for each patient and shaping treatment around their specific circumstances and goals.

“My philosophy of care is simple,” he said. “My profession is a privilege, and I strongly emphasize the service commitment to care to achieve the best outcomes for patients. And that is only done in the setting of good collaboration and teamwork.”

Publications of Dr. Wigfield 

• Wigfield, C. et al. (2017, March). Patient factors associated with lung transplant referral and waitlist for patients with cystic fibrosis and pulmonary fibrosis. Retrieved from https://www.jhltonline.org/article/S1053-2498(16)30297-2/fulltext
• Wigfield, C. (2014, October). Donation after cardiac death for lung transplantation: a review of current clinical practice. Retrieved from https://www.ovid.com/jnls/co-transplantation/abstract/10.1097/mot.0000000000000115~donation-after-cardiac-death-for-lung-transplantation-a?redirectionsource=fulltextview
• Wigfield, C. et al. (2012, June). Cellular Basis of Tissue Regeneration by Omentum. Retrieved from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038368
• Wigfield, C. et al. (2009, December). Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection. Retrieved from https://journals.lww.com/transplantjournal/abstract/10.1097/tp.0b013e3181bcde7b~transfer-of-tolerance-to-collagen-type-v-suppresses?redirectionsource=fulltextview